Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FUYLK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,148
Award facts
- Contract value 100% obligated
- $4,147.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for DUPIXENT 300 MG/2 ML pen injections with a ceiling value of $4,147.68 under a firm fixed price contract type. The award was made on September 3, 2025, with an ultimate completion date of September 4, 2025, with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal healthcare vendor that supplies a broad portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to support military and veteran healthcare systems. The company has demonstrated significant capability in fulfilling federal procurement requirements through competitive awards, with its DLA contract portfolio encompassing specialty medications and medical supplies across multiple therapeutic domains serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. DUPIXENT (dupilumab) is a biologic medication used to treat moderate-to-severe atopic dermatitis and other allergic conditions, making this delivery order part of AmerisourceBergen's ongoing support of military medical readiness and personnel healthcare needs.
Quick answers
Who was awarded contract SPE2DB25FUYLK?
SPE2DB25FUYLK was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 3, 2025.
How much is contract SPE2DB25FUYLK worth?
The government has obligated $4,148 on SPE2DB25FUYLK.
Is contract SPE2DB25FUYLK an order under another contract?
Yes. SPE2DB25FUYLK is a delivery order under SPE2DB25D3018, an indefinite delivery contract.
Was contract SPE2DB25FUYLK competed?
The extent of competition for SPE2DB25FUYLK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award